BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 4,700 shares, a growth of 6.8% from the December 31st total of 4,400 shares. Based on an average daily trading volume, of 6,700 shares, the short-interest ratio is presently 0.7 days.

BioNxt Solutions Stock Down 3.3 %

OTCMKTS:BNXTF opened at $0.27 on Tuesday. BioNxt Solutions has a 12-month low of $0.11 and a 12-month high of $0.51. The firm has a market capitalization of $30.72 million, a P/E ratio of -6.77 and a beta of 0.69. The stock’s fifty day simple moving average is $0.25 and its 200-day simple moving average is $0.20.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its quarterly earnings data on Friday, November 29th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.